The Latest in Thrombosis

PRAC finds insufficient evidence of difference between FVIII products

May 7, 2017

Therapy receives orphan designation for hemophilia A

May 5, 2017

Thrombosis

FDA grants therapy fast track status for hemophilia B

May 5, 2017

Thrombosis

Group publishes guidance for V/Q imaging in PE

May 4, 2017

Thrombosis

Heavily promoted drugs provide less ‘health value,’ study suggests

May 3, 2017

How choline increases the risk of thrombotic events

April 28, 2017

Thrombosis

TXA lowers risk of death from post-partum hemorrhage

April 27, 2017

Thrombosis

Treatment granted PRIME designation for hemophilia B

April 26, 2017

Thrombosis

TGA approves therapy for hemophilia A

April 21, 2017

Thrombosis

Early prophylaxis may preserve joint health in hemophilia patients

April 17, 2017

Thrombosis

Therapy increases factor IX activity in hemophilia B

April 14, 2017

Thrombosis

Portal allows hemophilia patients to share data with providers

April 13, 2017

Thrombosis

Factor IX therapy seems safe, effective in young kids

April 11, 2017

Thrombosis

FDA clears direct-to-consumer marketing of genetic risk tests

April 7, 2017

Rule identifies women at low risk of VTE recurrence

April 5, 2017

Thrombosis